Literature DB >> 15333591

European Classification of Infertility Taskforce (ECIT) response to Habbema et al., 'Towards less confusing terminology in reproductive medicine: a proposal'.

Julian Jenkins1, Salim Daya, Jan Kremer, Juan Balasch, Chris Barratt, Ian Cooke, James Lawford-Davies, Petra De Sutter, Anne Marie Suikari, Joseph Neulen, Karl Nygren.   

Abstract

The European Classification of Infertility Taskforce (ECIT) has been formed by ESHRE to develop a set of infertility-related codes (descriptions, interventions and outcomes) appropriate for computerization (http://www.ecit.info). In this article, ECIT reflects on previous suggestions in this Debate series, agreeing with the weaknesses of the current terminology used in reproductive medicine. Although ECIT is enthusiastic about the extension of terminology, caution is raised in abandoning familiar terms that may lead to greater rather than less confusion. Instead, ECIT suggests a way forward using structured computerized statements to retain current terms but extend their meaning.

Mesh:

Year:  2004        PMID: 15333591     DOI: 10.1093/humrep/deh499

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain.

Authors:  Marcos Ferrando; Buenaventura Coroleu; Luis Rodríguez-Tabernero; Gorka Barrenetxea; Cristina Guix; Fernando Sánchez; Julian Jenkins
Journal:  Fertil Res Pract       Date:  2020-07-29

Review 2.  Putative adverse outcome pathways for female reproductive disorders to improve testing and regulation of chemicals.

Authors:  Hanna K L Johansson; Pauliina Damdimopoulou; Majorie B M van Duursen; Julie Boberg; Delphine Franssen; Marijke de Cock; Kersti Jääger; Magdalena Wagner; Agne Velthut-Meikas; Yuling Xie; Lisa Connolly; Pauline Lelandais; Severine Mazaud-Guittot; Andres Salumets; Monica Kam Draskau; Panagiotis Filis; Paul A Fowler; Sofie Christiansen; Anne-Simone Parent; Terje Svingen
Journal:  Arch Toxicol       Date:  2020-07-07       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.